Best Kinase Inhibitor for leukemia, myeloid
4 Kinase Inhibitor drugs indicated for leukemia, myeloid, ranked by our independent rating. The current highest-rated is sprycel. Compare them with all treatments for leukemia, myeloid or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Top kinase inhibitor for leukemia, myeloid: 1. Sprycel · 2. Gleevec · 3. Imkeldi
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Sprycel | 72/100 | Prescription | $876 | View → |
| 2 | Gleevec | 68/100 | Prescription | $26 | View → |
| 3 | Imkeldi | Not yet rated |
Full ranking · 4 drugs
Frequently asked
- What is the best kinase inhibitor for leukemia, myeloid?
- By our independent rating, sprycel currently ranks highest among Kinase Inhibitor drugs used for leukemia, myeloid. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which kinase inhibitor drugs treat leukemia, myeloid?
- pharmaranks lists 4 Kinase Inhibitor products indicated for leukemia, myeloid, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
